Reappraisal of the essential fatty acids

Fatty Acids in Foods and their Health Implications, Third Edition

Volumn , Issue , 2007, Pages 675-691

  Chapkin, Robert S ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYUNSATURATED FATTY ACIDS;

CRITICAL ISSUES; ESSENTIAL FATTY ACIDS; LABORATORY ANIMALS; LINOLENIC ACIDS; PHYSIOLOGICAL FUNCTIONS; POLYUNSATURATED FATTY ACIDS (PUFAS);

LINOLEIC ACID;

EID: 77952104940     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (196)

1. Akbar, M., Calderon, F., Wen, Z., and Kim, H.Y. (2005). Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proc. Natl. Acad. Sci. (USA)102: 10858-10863.
2. Alfin-Slater, R.B., and Aftergood, L. (1968). Essential fatty acids. Physiol. Rev.48: 758-784.
3. Agostoni, C., Riva, E., Trojan, S., Bellu, R., and Giovannini, M. (1995). Docosahexaenoic acid status and developmental quotient of healthy term infants. Lancet 346: 638.
4. Anderson, R.E., and Sperling, L. (1971). Lipids of ocular tissues. VII. Positional distribution of the fatty acids in the phospholipids of bovine retina rod outer segments. Arch. Biochem. Biophys.144: 673-677.
5. Anderson, R.G.W. (2003). Joe Goldstein and Mike Brown: from cholesterol homeostasis to new paradigms in membrane biology. Trends Cell Biol. 13: 534-539.
6. Anonymous (1995). WHO and FAO joint consultation: fats and oils in human nutrition. Nutr. Rev.53: 202-205.
7. Bagga, D., Wang, L., Farias-Eisner, R., Glaspy, J.A., and Reddy, S.T. (2003). Differential effects of prostaglandin derived from ra-6 and ra-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc. Natl. Acad. Sci.100: 1751-1756.
8. Bailey, J.M. (1980). Essential fatty acid requirements and metabolism of cells in tissue culture. Adv. Prost. Throm. Res.6: 549-565.
9. Bernsohn, J., and Spitz, FJ. (1974). Linoleic and linolenic acid dependency of some brain membrane-bound enzymes after lipid deprivation in rats. Biochem. Biophys. Res. Comm.57: 293-298.
10. Biagi, P.L., Hrelia, S., Stefanini, G.F., Zunarelli, P., and Bordoni, A. (1990). Delta-6-desaturase activity of human liver microsomes from patients with different types of liver injury. Prost. Leuk. Essent. Fatty Acids 39: 39-42.
11. Birch, E.E., Castaneda, Y.S., Wheaton, D.H., Birch, D.G., Uauy, R.D., and Hoffman, D.R. (2005). Visual maturation of term infants fed long-chain polyunsaturated fatty acid-supplemented or control formula for 12 mo. Am. J. Clin. Nutr.81: 871-879.
12. Bivins, B.A., Bell, R., Rapp, R.P., and Griffen, W.O. (1983). Linoleic acid versus linolenic acid: What is essential? J. Parent. Ent. Nutr.7: 473-478.
13. Bjerve, K.S., Fischer, S., and Alme, K. (1987a). alpha-linolenic acid deficiency in man: effect of ethyl lino-lenate on plasma and erythrocyte fatty acid composition and biosynthesis of prostanoids. Am. J. Clin. Nutr.46: 570-576.
14. Bjerve, K.S., Mostad, I.L., and Thorensen, L. (1987b). alpha-linolenic acid deficiency in patients on long-term gastric-tube feeding: estimation of linolenic acid and long chain unsaturated n-3 fatty acid requirement in man. Am. J. Clin. Nutr.45: 66-77.
15. Bjerve, K.S., Fischer, S., Wammer, F., and Egeland, T. (1989). α-linolenic acid and long chain ra-3 fatty acid supplementation in three patients with ra-3 fatty acid deficiency: effect on lymphocyte function, plasma and red cell lipids, and prostanoid formation. Am. J. Clin. Nutr. 49: 290-300.
16. Botolin, D., Wang, Y., Christian, B., and Jump, D.B. (2006). Docosahexaenoic acid (22:6, n-3) regulates rat hepatocyte SREBP-1 nuclear abundance by Erk- and 26S proteosome-dependent pathways. J. Lipid Res.47: 181-192.
17. Bourre, J.M., Dument, O., Piciotti, M., Pascal, G., and Durand, G. (1989a). Polyunsaturated fatty acids of the n-3 series and nervous system development. Dietary m3 and m6 Fatty Acids. Biological Effects and Nutritional Essentiality (C. Galli and A.P. Simopoulos, eds.), Plenum Press, New York, pp. 159-175.
18. Bourre, J.M., Francois, M., Youyou, A., Dumont, O., Piciotti, M., Pascal, G., and Durand, G. (1989b). The effects of dietary α-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. J. Nutr119: 1880-1892.
19. Bouwstra, H., Dijck-Brouwer, D.A., Lildeman, J.A., Tjoonk, H.M., van der Heide, J.C., Boersma, E.R., Muskiet, F.A., and Hadders-Algra, M. (2003). Long-chain polyunsaturated fatty acids have a positive effect on the quality of general movements of healthy term infants. Am. J. Clin. Nutr. 78: 313-318.
20. Brenner, R.R. (1981). Nutritional and hormonal factors influencing desaturation of essential fatty acids. Prog. Lipid Res. 20: 41-47.
21. Brenner, R.R., Gorda, H., DeGomez Dumm, I.N.T., and Pezzano, H. (1981). Early effects of EFA deficiency on the structure and enzymatic activity of rat liver microsomes. Prog. Lipid Res. 20: 315-321.
22. Brenner, R.R., and Peluffo, R.O. (1969). Regulation of unsaturated fatty acid biosynthesis. I. Effect of unsaturated fatty acid of 18 carbons on the microsomal desaturation of linoleic acid into α-linolenic acid. Biochim. Biophys. Acta 176: 471-479.
23. Brown, M.S., and Goldstein, J.L. (1997). The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89: 331-340.
24. Burchfiel, C.M., Reed D.M., Strong, J.P., Sharp, D.S., Chyou, P., and Rodriguez, B.L. (1996). Predictors of myocardial lesions in men with minimal coronary atherosclerosis at autopsy. The Honolulu heart program. Ann. Epidemiol. 6: 137-146.
25. Burdge, G.C., Jones, A.E., and Wooton, S.A. (2002a). Eicosapentaenoic and docosapentaenoic acids are the principal products of α-linolenic acid metabolism in young men. Br. J. Nutr. 88: 355-363.
26. Burdge, G.C., and Wooten, S.A. (2002b). Conversion of α-linolenic acid to eicosapentaenoic, docosapentaenoic acids in young women. Br. J. Nutr. 88: 411-420.
27. Burr, G.O., and Burr, M.M. (1929). New deficiency disease produced by the rigid exclusion of fat from the diet. J. Biol. Chem. 82: 345-367.
28. Burr, G.O., and Burr, M.M. (1930). On the nature and role of the fatty acids essential in nutrition. J. Biol. Chem. 86: 587-621.
29. Calon, F., Lim, G.P., Yang, F., et al. (2004). Docosahexaenoic acid protects from dendritic pathology in an Alzheimer’s disease mouse model. Neuron 43: 633-645.
30. Calon, F., Lim, G.P., Morihara, T., Yang, F., Ubeda, O., Salem, N., Frautschy, S.A., and Cole, G.M. (2005). Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer’s disease. Eur. J. Neurosci. 22: 617-626.
31. Carlson, S.E. (2001). Docosahexaenoic acid and arachidonic acid in infant development. Semin. Neonatol. 6: 437-449.
32. Carlson, S.E., Clandinin, M.T., Cook, H.W., Emken, E.A., and Filer, L.J. (1997). Trans fatty acids: infant and fetal development. Am. J. Clin. Nutr. 66: 717S-736S.
33. Carlson, S.E., Werkman, S.H., Peeples, J.M., Cooke, R.J., and Tolley, E.A. (1993). Arachidonic acid status correlates with first year growth in preterm infants. Proc. Natl. Acad. Sci. (USA) 90: 1073-1077.
34. Carrillo-Tripp, M., and Feller, S.E. (2005). Evidence for a mechanism by which ω-3 polyunsaturated lipids may affect membrane protein function. Biochemistry 44: 10164-10169.
35. Cho, H.P., Nakamura, M.T., and Clarke, S.D. (1999a). Cloning, expression, and nutritional regulation of the mammalian A-6 desaturase. J. Biol. Chem. 274: 471-477.
36. Cho, H.P., Nakamura, M., and Clarke, S.D. (1999b). Cloning, expression, and fatty acid regulation of the human A-5 desaturase. J. Biol. Chem. 274: 37335-37339.
37. Cho, Y., and Ziboh, V.A. (1994). Expression of protein kinase C isozymes in guinea pig epidermis: selective inhibition of PKC-P activity by 13-hydroxyoctadecadienoic acid-containing diacylglycerol. J. Lipid Res. 35: 913-921.
38. Connor, W.E. (1997). Do the n-3 fatty acids from fish Prevent deaths from cardiovascular disease? Am. J. Clin. Nutr. 66: 188-189.
39. Contreras, M.A., and Rapoport, S.I. (2002). Recent studies on interactions between n-3 and n-6 polyunsaturated fatty acids in brain and other tissues. Curr. Opin. Lipidol. 13: 267-272.
40. Corella, D., and Ordovas, J.M. (2005). Single nucleotide polymorphisms that influence lipid metabolism: interaction with dietary factors. Annu. Rev. Nutr. 25: 341-390.
41. Crawford, M.A. (1992). The role of dietary fatty acids in biology: their place in the evolution of the human brain. Nutr. Rev. 50: 3-11.
42. Cunnane, S.C. (1996). Recent studies on the synthesis, P-oxidation, and deficiency of linoleate and a-linolenate: are essential fatty acids more aptly named indispensible or conditionally dispensible fatty acids? Can. J. Physiol. Pharmacol. 74: 629-639.
43. Cuthbertson, W.F.J. (1976). Essential fatty acid requirements in infancy. Am. J. Clin. Nutr. 29: 559-568.
44. Daleke, D.L. (2003). Regulation of transbilayer plasma membrane phospholipids asymmetry. J. Lipid Res. 44: 233-242.
45. Daviglus, M.L., Stamler, J., Orencia, A.J., Dyer, A.R., Liu, K., Greenland, P., Walsh, M.K., Morris, D., and Shekelle, R.B. (1997). Fish consumption and the 30-year risk of fatal myocarcial infarction. N. Engl. J. Med. 336: 1046-1053.
46. DeGomez Dumm, I.N.T., and Brenner, R.R. (1975). Oxidative desaturation of α-linolenic, linoleic, and stearic acids by human liver microsomes. Lipids 10: 315-317.
47. Demmelmair, H., Schenck, U.V., Behrendt, E., Sauerwald, T., and Koletzko, B. (1995). Estimation of arachidonic acid synthesis in full term neonates using natural variation of 13C content. J. Pediatr. Gastroenterol. Nutr. 21: 31-36.
48. Dyck, PJ., Yao, J.K., Knickerbocker, D.E., Holman, R.T., Gomez, M.R., Hayles, A.B., and Lambert, E.H. (1981). Multisystem, neuronal degeneration, hepatosplenomegaly, and adrenocortical deficiency associated with reduced tissue arachidonic acid. Neurology 31: 925-934.
49. Dyerberg, J. (1986). Linolenate-derived polyunsaturated fatty acids and Prevention of atherosclerosis. Nutr. Rev. 44: 125-134.
50. El Boustani, S., Causse, J.E., Descomps, B., Monnier, L., Mendy, F., and Crastes de Paulet, A. (1989). Direct in vivo characterization of delta 5 desaturase activity in humans by deuterium labeling: effect of insulin. Metabolism 38: 315-321.
51. Emken, E.A., Adlof, R.O., Rakoff, H., and Rohwedder, W.K. (1988). Metabolism of deuterium-labeled linolenic, linoleic, oleic, stearic and palmitic acid in human subjects. Synthesis and applications of isotopically labeled compounds. Proceedings of the Third International Symposium (T.A. Baillie and J.R. Jones, eds.), Innsbruck, Austria, pp. 713-716.
52. Emken, E.A., Adlof, R.O., Rakoff, H., Rohwedder, W.K., and Gulley, R.M. (1990). In vivo metabolism of deuterium-labeled linolenic and linoleic acids in humans. Biochem. Soc. Trans. 18: 766-769.
53. Emken, E.A., Adlof, R.O., and Gulley, R.M. (1994). Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim. Biophys. Acta 1213: 277-288.
54. Emken, E.A., Adlof, R.O., Duval, S.M., and Nelson, G.J. (1997). Influence of dietary arachidonic acid on metabolism in vivo of 8 cis, 11 cis, 14-eicosatrienoic acid in humans. Lipids 32: 441-448.
55. Emken, E.A., Rohweddar, W.K., Adlof, R.O., Rokoff, H., and Gulley, R.M. (1987). Metabolism in humans of cis-12, trans,-15-octadecadienoic acid relative to palmitic, stearic, oleic and linoleic acids. Lipids 22: 495-504.
56. Fan, Y.Y., Spencer, T.E., Wang, N., Moyer, M.P., and Chapkin, R.S. (2003). Chemoprotective n-3 fatty acids activate RXRa in colonocytes. Carcinogenesis 24: 1541-1548.
57. Farrell, P.M., Gutcher, G., Palta, M., and DeMets, D. (1988). Essential fatty acid deficiency in premature infants. Am. J. Clin. Nutr. 48: 220-229.
58. Fiennes, R.N.T.W., Sinclair, A.J., and Crawford, M.A. (1973). Essential fatty acid studies in primates: linolenic acid requirement of capuchins. J. Med. Prim. 2: 155-169.
59. Fleith, M., and Clandinin, M.T. (2005). Dietary PUFA for preterm and term infants: review of clinical studies. Crit. Rev. Food Sci. Nutr. 45: 205-229.
60. Garner, W.L., Oyatsu, Y., Zuccaro, C., Rodriquez, J.L., Smith, J.D., and Marcelo, C.L. (1995). The effect of essential fatty acid supplementation on keratinocyte replication. Prost. Leuk. Essent. Fatty Acids 52: 349-355.
61. German, J.B., Dillard, C.J., and Whelan, J. (1995). Biological effects of dietary arachidonic acid. J. Nutr. 126: 1076S-1080S.
62. Glatz, J.F.C., and vand der Vusse, G.J. (1996). Cellular fatty acid-binding proteins: their function and physiological significance. Prog. Lipid Res. 15: 243-282.
63. Gourley, G.R., Farrell, P.M., and Odell, G.B. (1982). Essential fatty acid deficiency after hepatic portoenterostomy for biliary atresia. Am. J. Clin. Nutr. 36: 1194-1199.
64. Grammatikos, S.I., Subbaiah, P.V., Victor, T.A., and Miller, W.M. (1994). Diversity in the ability of cultured cells to elongate and desaturate essential (n-6 and n-3) fatty acids. Ann. NY Acad. Sci. 745: 92-105.
65. Hamazaki, T., Fischer, S., Urakaze, M., Sawazaki, S., Yano, S., and Kuwamori, T. (1989). Urinary excretion of PGI2/3-M and recent n-6/3 fatty acid intake. Prostaglandins 37: 417-424.
66. Hamilton, J.A., Guo, W., and Kamp, F. (2002). Mechanism of cellular uptake of long-chain fatty acids: do we need cellular proteins. Mol. Cell. Biochem. 239: 17-23.
67. Hancock, J.F. (2006). Lipid rafts: contentious only from simplistic standpoints. Nature Rev. Mol. Cell Biol. 7: 456-462.
68. Hansen, A.E., Weise, H.F., Boelsche, A.N., Haggard, M.E., Adam, D.J.D., and Davis, H. (1963). Role of linoleic acid in infant nutrition. Pediatrics II Suppl. pp. 171-191.
69. Hansen, H.S., Jensen B., and VonWeltstein-Knowles, P. (1986). Apparent in vivo retroconversion of dietary arachidonic acid to linoleic acid in essential fatty acid deficient rats. Biochim. Biophys. Acta 878: 284-287.
70. Helms, J.B., and Zurzolo, C. (2004). Lipids as targeting signals: lipid rafts and intracellular trafficking. Traffic 5: 247-254.
71. Hernell, O., Holmgren, G., Jagell, F., Johnson, S.B., and Holman, R.T. (1982). Suspected faulty essential fatty acid metabolism in Sjogren-Larsson syndrome. Pediatr. Res. 16: 45-49.
72. Hill, G. G., and Holman, R.T. (1980). Effect of dietary protein level upon essential fatty acid (EFA) deficiency. J. Nutr. 110: 1057-1060.
73. Hoffman, D.R., Birch, E.E., Birch, D.G., and Uauy, R.D. (1993). Effects of supplementation with m3 long- chain polyunsaturated fatty acids on retinal and cortical development in permature infants. Am. J. Clin. Nutr. 57: 807S-812S.
74. Holman, R.T. (1960). The ratio of trienoic:tetraenoic acids in tissue lipids as a measure of essential fatty acid requirement. J. Nutr. 70: 405-410.
75. Holman, R.T. (1971). Essential fatty acid deficiency. Prog. Chem. Fats Other Lipids 9: 275-348.
76. Holman, R.T. (1977). Essential fatty acids in human nutrition. Adv. Exp. Med. 88: 515-534.
77. Holman, R.T., Adams, C.E., Nelson, R.A., Grater, S.J.E., Jaskiewicz, J.A., Johnson, S.B., and Holman, R.T. (1995). Patients with anorexia nervosa demonstrate deficiencies of selected essential fatty acids, compensatory changes in nonessential fatty acids and decreased fluidity of plasma lipids. J. Nutr. 125: 901-907.
78. Holman, R.T., Johnson, S.B., Mercuri, O., Itarte, H.J., Rodrigo, M., and De Tomas, M.E. (1981). Essential fatty acid deficiency in malnourished children. Am. J. Clin. Nutr. 34: 1534-1539.
79. Holman, R.T., Johnson, S.B., and Hatch, T.F. (1982). A case of human linolenic acid deficiency involving neurological abnormalities. Am. J. Clin. Nutr. 35: 617-623.
80. Holman, R.T., Smythe, L., and Johnson, S. (1979). Effect of sex and age on fatty acid composition of human serum lipids. Am. J. Clin. Nutr. 32: 2390-2399.
81. Horrobin, D.F., and Cunnane, S.C. (1981). Is the triene/tetraene ratio always a valid indicator of functional essential fatty acid deficiency. Prog. Lipid Res. 20: 831-833.
82. Houtsmuller, U.M.T. (1975). Specific biological effects of polyunsaturated fatty acids, in The Role of Fats in Human Nutrition (A.J. Vergroesen, ed.), Academic Press, London, pp. 331-351.
83. Hu, F.B., Cho, E., Rexrode, K.M., Albert, C.M., and Manson, J.E. (2003). Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation 107: 1852-1857.
84. Hussein, N., Ah-Sing, E., Wilkinson, P., Leach, C., Griffin, B.A., and Millward, D.J. (2005). Long-chain conversion of [13C]linoleic acid and α-linolenic acid in response to marked changes in their dietary intake in men. J. Lipid Res. 46: 269-280.
85. Ikemoto, A., Ohishi, M., Sato, Y., Hata, N., Misawa, Y., Fujii, Y., and Okuyama, H. (2001). Reversibility of n-3 fatty acid deficiency-induced alterations of learning behavior in the rat: level of n-6 fatty acids as another critical factor. J. Lipid Res. 42: 1655-1663.
86. Innis, S.M., and Elias, S.L. (2003). Intakes of essential n-6 and n-3 polyunsaturated fatty acids among pregnant Canadian women. Am. J. Clin. Nutr. 77: 473-478.
87. Innis, S.M., Nelson, C.M., Lwanga, D., Rioux, F.M., and Waslen, P. (1996). Feeding formula without arachidonic acid and docosahexaenoic acid has no effect on preferential looking acuity or recognition memory in healthy full-term infants at 9 mo of age. Am. J. Clin. Nutr. 64: 40-46.
88. Institute of Medicine of the National Academies (2005). In: Dietary Reference Intakes, National Academy Press, Washington, DC.
89. ISSFAL (2004). Recommendations for intake of polyunsaturated fatty acids in healthy adults. www.issfal.org.uk.
90. James, M.J., Ursin, V.M., and Cleland, L.G. (2003). Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids. Am. J. Clin. Nutr. 77: 1140-1145.
91. Jeppesen, P.B., Christensen, M.S., Hoy, C.E., and Mortensen, P.B. (1997). Essential fatty acid deficiency in patients with severe fat malabsorption. Am. J. Clin. Nutr. 65: 837-843.
92. Jump, D.B. (2002). The biochemistry of n-3 polyunsaturated fatty acids. J. Biol. Chem. 277: 8755-8758.
93. Jump, D.B., Botolin, D., Wang, Y., Xu, J., Christian, B., and Demeure, O. (2005). Fatty acid regulation of hepatic gene transcription. J. Nutr. 135: 2503-2506.
94. Kalmijn, S., Feskens, E.J.M., Launer, L.J., and Kromhout, D. (1997). Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am. J. Epidemiol. 145: 33-41.
95. Kang, J.X. (2005). From Fat to Fat-1: a tale of omega-3 fatty acids. J. Membrane Biol. 206: 165-172.
96. Katan, M.B., Deslypere, J.P., van Birgelen, A.P., Penders, M., and Zegwaard, M. (1997). Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J. Lipid Res. 38: 2012-2022.
97. Kelavkar, U.P., Glasgow, W., Olson, S.J., Foster, B.A., and Shappell, S.B. (2004). Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice. Neoplasia 6: 821-830.
98. Kinsella, J.E., Lokesh, B., Broughton, K.S., and Whelan, J.W. (1990). Dietary polyunsaturated fatty acids and eicosanoids: potential effects on the modulation of inflammatory and immune cells: an overview. Nutrition 6: 24-44.
99. Kliewer, S.A., Sundseth, S.S., Jones, S.A., et al. (1997). Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors a and y. Proc. Natl. Acad. Sci. (USA) 94: 4318-4323.
100. Knapp, H.R., Reilly, I.A.G., Alessandrini, P., and Fitzgerald, G.A. (1986). In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. New Engl. J. Med. 314: 937-942.
101. Koletzko, B. (1987). Omega-3 fatty acid requirement. Am. J. Clin. Nutr. 46: 374-376.
102. Koo, W.W. (2003). Efficacy and safety of docosahexaenoic acid and arachidonic acid addition to infant formulae: can one buy better vision and intelligence? J. Am. Coll. Nutr. 22: 101-107.
103. Kremer, J.M., Lawrence, D.A., Petrillo, G.F., et al. (1995). Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Arthritis Rheum. 38: 1107-1114.
104. Kris-Etherton, P.M., Harris, W.S., and Appel, L.J. (2002). Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106: 2747-2757.
105. Kris-Etherton, P.M., Taylor, D.S., Yu-Poth, S., Huth, P., Moriarty, K., Fishell, V., Hargrove, R.L., Zhao, G., and Etherton, T.D. (2000). Polyunsaturated fatty acids in the food chain in the United States. Am. J. Clin. Nutr. 71: 179S-188S.
106. Lai, L., Kang, J.X., Li, R., et al. (2006). Generation of cloned transgenic pigs rich in omega-3 fatty acids. Nature Biotech. 24: 435-436.
107. Lamptey, M.W., and Walker, B.L. (1976). A possible essential role for dietary linolenic acid in the development of the young rat. J. Nutr. 106: 86-93.
108. Lands, W.E.M. (1979). The biosynthesis and metabolism of prostaglandins. Ann. Rev. Physiol.41: 633-652.
109. Lands, W.E.M. (1989). n-3 Fatty acids as precursors for active metabolic substances: dissonance between expected and observed events. J. Internal. Med. 225 (Suppl. 1): 11-20.
110. Laposata, M., and Muszbek, L. (1996). Thioesterification of platelet proteins with saturated and polyunsaturated fatty acids. Lipids 31: S217-S221.
111. Lauritzen, I., Blondeau, N., Heurteaux, C., Widmann, C., Romey, G., and Lazdunski, M. (2000). Polyunsaturated fatty acids are potent neuroprotectors. EMBO J. 19: 1784-1793.
112. Lauritzen, L., Hansen, H.S., Jorgensen, M.H., and Michaelsen, K.F. (2001). The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog. Lipid Res.40: 1-94.
113. Leonard, A.E., Kelder, B., Bobik, E.G., Chuang, L.T., Lewis, C.J., Kopchick, J.J., Mukerji, P., and Huang, Y.S. (2002). Identification and expression of mammalian long-chain PUFA elongation enzymes. Lipids 37: 733-740.
114. Leonard, A.E., Pereira, S.L., Sprecher, H., and Huang, Y.S. (2004). Elongation of long-chain fatty acids. Prog. Lipid Res. 43: 36-54.
115. Lerner, R., Lindstrom, P., Berg, A., Johansson, E., Rosendahl, and Palmblad, J. (1995). Development and characterization of essential fatty acid deficiency in human endothelial cells in culture. Proc. Natl. Acad. Sci. (USA)92: 1147-1151.
116. Li, B., Birdwell, C., and Whelan, J. (1994). Antithetic relationship of dietary arachidonic acid and eicosapentaenoic acid on eicosanoid production in vivo. J. Lipid Res.35: 1869-1877.
117. Li, Y., Takayuki, Y., and Nakamura, M.T. (2005). Peroxisome proliferator-activated receptor ω is required for feedback regulation of highly unsaturated fatty acid synthesis. J. Lipid Res.46: 2432-2440.
118. Liang, X., Nazarian, A., Erdjument-Bromage, H., Bornmann, W., Tempst, P., and Resh, M.D. (2001). Heterogeneous fatty acylation of src family kinases with polyunsaturated fatty acids regulates raft localization and signal transduction. J. Biol. Chem.276: 30987-30994.
119. Lipillone, A., and Carlson, S.A. (2001). Polyunsaturated fatty acids and infant growth. Lipids36: 901-911.
120. Lukiw, W.J., Cui, J.G., Marcheselli, V.L., Bodker, M., Botkjaer, A., Golinger, K., Serhan, C.N., and Bazan, N.G. (2005). A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J. Clin. Invest. 115: 2774-2783.
121. Lupton, R.S., and Chapkin, R.S. (2004). ChemoPreventive effects of Omega-3 fatty acids, in Cancer Chemo Prevention; Vol I: Promising Cancer Chemo Preventive Agents (G.J. Kelloff, E.T. Hawk, and C.C. Sigman, eds.), Humana Press, Totowa, NJ, pp. 591-608.
122. Ma, D.W., Seo, J., Davidson, L.A., Callaway, E.S., Fan, Y.Y., Lupton, J.R., and Chapkin, R.S. (2004b). n-3 PUFA alter caveolae lipid composition and resident protein localization in mouse colon. FASEB J. e-print 10.1096/fj.o3-0604fje, 18: 1040-1042.
123. Ma, D.W., Seo, J., Switzer, K.C., Fan, Y.Y., McMurray, D.N., Lupton, J.R., and Chapkin, R.S. (2004a). n-3 PUFA and membrane microdomains: A new frontier in bioactive lipid research. J. Nutr. Biochem. 15: 700-706.
124. Mann, N.J., Johnson, L.G., Warrick, G.E., and Sinclair, A.J. (1995). The arachidonic acid content of the Australian diet is lower than Previously estimated. J. Nutr. 125: 2528-2535.
125. Mantzioris, E., James, M.J., Gibson, R.A., and Cleland, L.G. (1995). Differences exist in the relationships between dietary linoleic acid and α-linolenic acids and their respective long-chain metabolites. Am. J. Clin. Nutr.61: 320-324.
126. Mark, G., and Sanders, T.A. (1994). The influence of different amounts of n-3 polyunsaturated fatty acids on bleeding time and in vivo vascular reactivity. Br. J. Nutr.71: 43-52.
127. Marszalek, J.R., Kitidis, C., DiRusso, C.C., and Lodish, H.F. (2005). Long-chain acyl-CoA synthetase 6 preferentially promotes DHA metabolism. J. Biol. Chem.280: 10817-10826.
128. Martinez, M. (1990). Severe deficiency of docosahexaenoic acid in peroxisomal disorders: a defect in Δ4 desaturation? Neurology40: 1292-1298.
129. Mead, J.F. (1984). The non-eicosanoid functions of the essential fatty acids. J. Lipid Res.25: 1517-1521.
130. McCann, J.C., and Ames, B.N. (2005). Is docosahexaenoic acid, an n-3 long chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am. J. Clin. Nutr. 82: 281-295.
131. Mendy, F., Lasserre, M., Piganeau, P., Speilman, D., and Jacotot, B. (1986). Facts about linoleic acid metabolic fate during PUFA rich diets in humans, in Lipid Metabolism and Its Pathology (M.S. Halpern, ed.), Elsevier Press, pp. 213-223.
132. Menon, N.K., and Dhopeshwarkar, D. (1982). Essential fatty acid deficiency and brain development. Prog. Lipid Res.21: 309-326.
133. Miller, C.C., Ziboh, V.A., Wong, T., and Fletcher, M.P. (1990). Dietary supplementation with oils rich in (n-3) and (n-6) fatty acids influences in vivo levels of epidermal lipoxygenase products in guinea pigs. J. Nutr.1210: 36-44.
134. Mohrhauer, H., and Holman, R.T. (1963). The effect of dose level of essential acids upon fatty acid composition of the rat liver. J. Lipid Res.4: 151-159.
135. Moriguchi, T., and Salem, N. (2003). Recovery of brain docosahexaenoate leads to recovery of spatial task performance. J. Neurochem.87: 297-309.
136. Murphy, E.J., Owada, Y., Kitanaka, N., Kondo, H., and Glatz, J.F. (2005). Brain arachidonic acid incorporation is decreased in heart fatty acid binding protein gene-ablated mice. Biochemistry 44: 6350-6360.
137. Naismith, D.S., Deeprose, S.P., Supramaniam, G., and Williams, M.S.H. (1978). Reappraisal of linoleic acid requirements of the young infant, with particular regard to use of modified cows’ milk formulae. Arch. Dis. Childhood.53: 845-849.
138. Nakamura, M.T., and Nara, T.Y. (2004). Structure, function, and dietary regulation of A6, A5, and A9 desaturases. Annu. Rev. Nutr.24: 345-376.
139. Naughton, J.M. (1981). Supply of polyenoic fatty acids to the mammalian brain. Int. J. Biochem.13: 21-32.
140. Neuringer, M., Reisbick, S., and Janowsky, J. (1994). The role of n-3 fatty acids in visual and cognitive development: current evidence and methods of assessment. J. Pediatr.125: S39-S47.
141. Nichaman, M.Z., Olson, R.E., and Sweeley, C.C. (1967). Metabolism of linoleic acid 1-14C in normolipemic and hyperlipemic humans fed linoleate diets. Am. J. Clin. Nutr.20: 1070-1083.
142. Okuyama, H., Kobayashi, T., and Watanabe, S. (1997). Dietary fatty acids- the n-6/n-3 balance and chronic elderly diseases. Excess linoleic acid and relative n-3 deficiency syndrome seen in Japan. Prog. Lipid Res.35: 409-457.
143. Pawlosky, R.J., Hibbeln, J.R., Novotny, J.A., and Salem, N. (2001). Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J. Lipid Res.42: 1257-1265.
144. Pawlosky, R.J., Hibbeln, J.R., Lin, Y., Goodson, S., Riggs, P., Sebring, N., Brown, G.L., and Salem, N. (2003). Effects of beef- and fish-based diets on the kinetics of n-3 fatty acid metabolism in human subjects. Am. J. Clin. Nutr.77: 565-572.
145. Rahm, J.J., and Holman, R.T. (1964). Effect of linoleic acid upon the metabolism of linolenic acid. J. Nutr.84: 15-19.
146. Ratnayake, W.M.N., Chardigny, J.M., Wolff, R.L., Bayard, C.C., Sebedio, J.L., and Martine, L. (1997). Essential fatty acids and their trans geometrical isomers in powdered and liquid infant formulas sold in Canada. J. Pediatr. Gastroenterol. Nutr.25: 400-407.
147. Ren, B., Thelen, A.P., Peters, J.M., Gonzalez, F.J., and Jump, D.B. (1997). Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator- activated receptor α. J. Biol. Chem. 272: 26827-26832.
148. Rivers, J.P.W. (1984). On the essentiality of omega-3 polyunsaturated fatty acids. Br. J. Clin. Prac. 38(Suppl. 31): 100-110.
149. Rivers, J.P.W., and Frankel, T.L. (1981). Essential fatty acid deficiency. Brit. Med. Bull.37: 59-64.
150. Rosenthal, M.D. (1987). Fatty acid metabolism of isolated mammalian cells. Prog. Lipid Res.26: 87-124.
151. Samuelsson, B., Haeggstrom, J.Z., and Wetterholm, A. (1991). Leukotriene biosynthesis. Ann. NY Acad. Sci.629: 89-99.
152. Scott, B.L., and Bazan, N.G. (1989). Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proc. Natl. Acad. Sci.86: 2903-2907.
153. Seo, J., Barhoumi, R., Johnson, A.E., Lupton, J.R., and Chapkin, R.S. (2006). Docosahexaenoic acid selectively inhibits plasma membrane targeting of lipidated proteins. FASEB J. e-print 10.1096/fj.05-4683fje, 20: 770-772.
154. Serhan, C.N. (2005). Novel ra-3-derived local mediators in anti-inflammation and resolution. Pharmacol. Therap. 105: 7-21.
155. Serhan, C.N., and Savill, J. (2005). Resolution of inflammation: the beginning programs the end. Nature Immunol. 6: 1191-1197.
156. Sheaff, G., Zhang, Q., Goodman, K.J., Giussani, D.A., Nathanielsz, and Brenna, J.T. (1996). Linoleate, a-linolenate, and docosahexaenoate recycling into saturated and monounsaturated fatty acids is a major pathway in pregnant or lactating adults and fetal or infant rhesus monkeys. J. Lipid Res. 37: 2675-2686.
157. Siguel, E.N., and Lerman, R.H. (1996). Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders. Metabolism 45: 12-23.
158. Siguel, E.N., and Maclure, M. (1987). Relative activity of unsaturated fatty acid metabolic pathways in humans. Metabolism 36: 664-669.
159. Simopoulos, A.P. (1989a). Executive summary, in Dietary ra3 and ra6 Fatty Acids. Biological Effects and Nutritional Essentiality (C. Galli and A.P. Simopoulos, eds.), Plenum Press, New York, pp. 391-404.
160. Simopoulos, A.P. (1989b). Summary of the NATO advanced research workshop on dietary ra3 and ra6 fatty acids: biological effects and nutritional essentiality. J. Nutr.119: 521-528.
161. Simopoulos, A.P. (1996). The role of fatty acids in gene expression: health implications. Ann. Nutr. Metab.40: 303-311.
162. Smith, W.L. (2005). Cyclooxygenases, peroxide tone and allure of fish oil. Curr. Opin. Cell Biol.17: 174-182.
163. Spector, A.A., Mathur, S.N., Kaduce, T.L., and Hyman, B.T. (1981). Lipid nutrition and metabolism of cultured mammalian cells. Prog. Lipid Res.19: 155-186.
164. Sprecher, H. (1981). Biochemistry of essential fatty acids. Prog. Lipid Res. 20: 13-22.
165. Sprecher, H. (2000). Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim. Biophys. Acta 1486: 219-231.
166. Sprecher, H., Luthria, D.L., Mohammed, B.S., and Baykousheva, S.P. (1995). Reevaluation of the pathways for the biosynthesis of polyunsaturated fatty acids. J. Lipid Res.36: 2471-2477.
167. Stillwell, W., Shaikh, S.R., LoCascio, D., Siddiqui, R.A., Seo, J., Chapkin, R.S., and Wassall, J. (2006). Docosahexaenoic acid. An influential membrane-altering omega-3 fatty acid, in Frontiers in Nutrition Research (J.D. Huang, ed.), Nova Science Publishers, Inc., Hauppauge, NY.
168. Stoll, L.L., and Spector, A.A. (1995). Functional and ultrastructural effects of essential fatty acid deficiency in kidney epithelial cells. Lipids 30: 1093-1103.
169. Stone, K.J., Willis, A.L., Hart, M., Kirtland, S.J., Kernoff, P.B.A., and McNicol, G.P. (1979). The metabolism of dihomo-gamma-linolenic acid in man. LipidS 14: 174-180.
170. Stulnig, T.M. (2003). Immunomodulation by polyunsaturated fatty acids: mechanisms and effects. Int. Arch. Allergy Immunol.132: 310-321.
171. Tang, C., Cho, H.P., Nakamura, M.T., and Clarke, S.D. (2003). Regulation of human A-6 desaturase gene transcription: identification of a functional direct repeat-1 element. J. Lipid Res.44: 686-695.
172. Terry, P.D., Rohan, T.E., and Wolk, A. (2003). Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: a review of the epidemiologic evidence. Am. J. Clin. Nutr.77: 532-543.
173. Tinoco, J. (1982). Dietary requirements and functions of α-linolenic acid in animals. Prog. Lipid Res. 21: 1-45.
174. Tinoco, J., Babcock, R., Hincenbergs, I., Medwadowski, B., Jiljanich, P., and Williams, M.A. (1979). Linolenic acid deficiency. LipidS 14: 166-173.
175. Uauy, R., Peirano, P., Hoffman, D., Mena, P., Birch, D., and Birch, E. (1996). Role of essential fatty acids in the function of the developing nervous system. Lipids 31: S167-S176.
176. Ursin, V.M. (2003). Modification of plant lipids for human health: development of functional land-based omega-3 fatty acids. J. Nutr. 133: 4271-4274.
177. van Egmond, A.W.A., Kosorok, M.R., Koscik, R., Laxova, A., and Farrell, P.M. (1996). Effect of linoleic acid intake on growth of infants with cystic fibrosis. Am. J. Clin. Nutr. 63: 746-752.
178. Vidgren, H.M., Agren, J.J., Schwab, U., Rissanen, T., Hanninen, O., and Uusitupa, M.I. (1997). Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men. Lipids32: 697-705.
179. VillaLPAndo, S., Del Prado, M., Lance, A., Alfonso, E., Rodriguez, M., Demmelmair, H., and Koletzko, B. (2001). [13C]Linoleic acid oxidation and transfer into milk in stunted lactating women with contrasting body mass indexes. Am. J. Clin. Nutr. 74: 827-832.
180. Viola, A., Schroeder, S., Sakakibara, Y., and Lanzavecchia, A. (1999). T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 283: 680-682.
181. von Schacky, C., Fischer, S., and Weber, P.C. (1985). Long term effects of dietary marine ω-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J. Clin. Invest.76: 1626-1631.
182. Wang, D., and DuBois, R.N. (2004). Cyclooxygenase 2-derived prostaglandin E2 regulates the angiogenic switch. Proc. Natl. Acad. Sci. (USA)101: 415-416.
183. Warensjo, E., Ohrvall, M., and Vessby, B. (2006). Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women. Nutr. Metab. Cardio. Dis.16: 128-136.
184. Webb, Y., Hermida-Matsumoto, L., and Resh, M.D. (2000). Inhibition of protein palmitoylation, raft localization, and T cell signaling by 2-bromopalmitate and polyunsaturated fatty acids. J. Biol. Chem. 275: 261-270.
185. Wheeler, T.G., Benolken, R.M., and Anderson, R.E. (1975). Visual membranes: specificity of fatty acid precursors for the electrical response to illumination. Science 27: 1312-1314.
186. Whelan, J., and McEntee, M.F. (2004). Dietary (n-6) PUFA and intestinal tumorigenesis. J. Nutr. 134: 3421S-3426S.
187. Wright, K., Coverston, C., Tiedeman, M., and Abegglen, J.A. (2006). Formula supplemented with docosa- hexaenoic acid (DHA) and arachidonic acid (ARA): A critical review of the research. J. Spec. Pediatr. Nurs. 11: 100-112.
188. Xavier, R., Brennan, T., Li, Q., McComack, C., and Seed, B. (1998). Membrane compartmentalization is required for efficient T cell activation. Immunity 8: 723-732.
189. Xu, H.E., Lambert, M.H., Montana, V.G., et al. (1999). Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol. Cell 3: 397-403.
190. Yamamoto, N., Saitoh, M., Moriuchi, A., Nomura, M., and Okuyama, H. (1987). Effect of dietary a-linolenate/linoleate balance on brain lipid compositions and learning ability of rats. J. Lipid Res. 28: 144-155.
191. Yamamoto, N., Hasimoto, A., Takemoto, Y., Okuyama, H., Nomura, M., Kitajima, R., Togashi, T., and Tamai, Y. (1988). Effect of the dietary a-linolenate/linoleate balance on lipid composition and learning ability of rats. II. Discrimination process, extinction process, and glycolipid composition. J. Lipid Res. 29: 1013-1021.
192. Yamanaka, W.K., Clemans, G.W., and Hutchinson, M.L. (1981). Essential fatty acids deficiency in humans. Prog. Lipid Res.19: 187-215.
193. Yang, P., Chan, D., Felix, E., Cartwright, C., Menter, D.G., Madden, T., Klein, R.D., Fischer, S.M. and Newman, R.A. (2004). Formation of antiproliferative effect of prostaglandin E3 form eicosapentaenoic acid in human lung cancer cells. J. Lipid Res.45: 1030-1039.
194. Zhou, L., and Nilsson, A. (2001). Sources of eicosanoid precursor fatty acid pools in tissues. J. Lipid Res.42: 1521-1542.
195. Ziboh, V.A., and Chapkin, R.S. (1988). Metabolism and function of skin lipids. Prog. Lipid Res.27: 81-105.
196. Zuo, X., Wu, Y., Morris, J.S., Stimmel, J.B., Leesnitzer, L.M., Fischer, S.M., Lippman, S.M. and Shureiqi, I. (2006). Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR- gamma activity. Oncogene 25: 1225-1241.